PEDIATRICS Vol. 98 No. 6 December 1996, pp. 1222
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRIFFIN, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRIFFIN, G. C.

Encouraging Teens to Use Norplant Is Bad Advice

GLEN C. GRIFFIN MD, FAAP

An American Academy of Pediatrics (AAP) news release trumpeted misinformation to the world from the seriously flawed conclusions of an article in the February 1996 issue of Pediatrics. This press release and seemingly scientific article conclude that "Health care workers must work to remove barriers . . . so young patients who wish to avoid pregnancy will view Norplant as a contraceptive alternative." This is just plain bad advice. Why "work" for an objective that causes more problems? Although Norplant may protect a teen from pregnancy, it certainly does not protect a teen from acquired immunodeficiency syndrome (AIDS), which is 100% fatal, or any other sexually transmitted disease (SID).